Restoring Endo-Lysosomal Function: Translational Biomarkers to Accelerate Parkinson’s Therapeutics
- Discovering metabolomic and lipidomic signatures of endolysosomal dysfunction in PD patients and healthy controls to define disease-relevant biomarker baselines
- Validating pharmacodynamic biomarkers via small molecule target manipulation in cell and patient-derived samples to track treatment effects early in the pipeline
- Accelerating drug discovery by using these biomarkers to derisk candidate selection, inform dose selection, and shorten time to clinical proof-of-concept in Parkinson’s
- As a speaker, you will receive complimentary registration to the full 3 days of the event as my guest, we only ask that speakers cover their travel and accommodation